Wellington Shields Capital Management LLC Grows Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Wellington Shields Capital Management LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1,753.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 39,663 shares of the financial services provider’s stock after buying an additional 37,523 shares during the period. Wellington Shields Capital Management LLC owned 0.09% of iShares Biotechnology ETF worth $5,244,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the third quarter worth about $29,000. HHM Wealth Advisors LLC raised its position in shares of iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $32,000. Newbridge Financial Services Group Inc. bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.8 %

IBB opened at $133.14 on Friday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The company has a market cap of $6.29 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. The stock has a fifty day simple moving average of $136.24 and a two-hundred day simple moving average of $140.01.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.